Popular Articles

Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
Data presented yesterday, in Budapest, demonstrated that add-on treatment with the novel, once-daily anti-epileptic Zebinix®* (eslicarbazepine acetate; ESL) resulted in a marked and sustained decrease in seizure frequency over the long-term. Results from the one-year extension of a pivotal Eslicarbazepine Acetate phase III study were presented at the International Congress for Epilepsy in Budapest, Hungary. Patients not controlled with existing anti-epileptic drugs who were given eslicarbazepine acetate as an add-on treatment experienced a mean reduction in seizure frequency of more than 61% (95%CI: -68.2%, -55.5%). Nearly 65% of patients were classified as responders, meaning that they had achieved at least a 50% reduction in seizure frequency with Zebinix® treatment1.
pharmacy online
Infant Medicine Feeder Delivers Incorrect Dose
Parents of babies and young children are being urged to stop using the "First Steps" medicine feeder range manufactured by RSW International Ltd after the Medicines and Healthcare products Regulatory Agency (MHRA) uncovered potential safety and quality concerns.
News of the day
No Improvement In Detecting Cervical Cancer With Addition Of HPV Test In Cervical Screening Programme In The UK
An article published Online First and in the July edition of The Lancet Oncology reports that the combination of human papillomavirus (HPV) testing with regular liquid-based cytology (LBC) screening does not improve the detection of cervical cancer compared with LBC screening alone.
Medical Devices

Government Must Take Care Not To Raise Expectations Beyond What NHS Can Deliver - The King's Fund, UK

Commenting on the health announcements contained in Building Britain"s Future, The King"s Fund chief executive Niall Dickson said: "The idea that patients should have a right to certain standards of treatment is a good one and the government should be congratulated on reducing the number of central targets, some of which were hard to justify. However, we do need to be clear that many of the "rights" set out in the Prime Minister"s announcement are currently "must do"s" for the NHS. For example, the four hour maximum wait in accident and emergency, the 18 week wait for hospital treatment and health checks for 40 year olds are all already in operation. "The announcement today also suggests the government will have to strengthen the new NHS Constitution, which was only launched a few months ago. "The other concern must be that the new rights raise expectations among patients that the NHS may find hard to deliver. For example the guarantee of access to NHS dentistry and to enable patients with long term conditions to die at home are laudable ambitions but if the service cannot achieve that standard immediately, there is a risk of alienating staff and frustrating patients. "Nor should we forget that NHS targets, although unpopular and sometimes misguided, did play a vital role in driving the dramatic decreases in waiting times over the past 12 years." 1. 18-week waits The NHS Improvement Plan (2004) established a maximum wait of 18 weeks from the time of GP referral to a hospital consultant, to the start of treatment. The target was effectively met on time, at the end of 2008. The latest data shows that the ongoing performance targets continue to be met: at April 2009 93% of admitted patients were seen within 18 weeks (within the target of 90%) and 97% of non-admitted patients were seen within 18 weeks (within the target of 95%). 2. A&E 4-hour target This NHS Plan (2000) target stated that by 2004 all patients attending accident and emergency departments should be treated, discharged or admitted within four hours of arrival. This was later refined in 2003 to a requirement that the target be met for 98% of patients. The target was missed only very narrowly - in the first quarter of 2005, 97 per cent of patients were seen within this time. In 2008/09 - 98% of patients spent 4 hours or less from arrival to admission, transfer or discharge (link ). 3. Check ups for 40+ year olds Then Secretary of State for Health Alan Johnson announced plans for everyone aged 40-74 to be offered a single, integrated check to assess risk of vascular disease (heart disease, stroke, diabetes and kidney disease) in April 2008 . Details of the programme are outlined in Putting Prevention First (2008). The Department of Health estimates that there will be 3 million tests a year, at an estimated cost of ÷£250m per year. Implementation began in April 2009 . http://www.dh.gov.uk/en/News/Recentstories/DH_097147 Online health MOTs - called NHS Lifecheck - were developed in 2006 after a commitment in Our Health Our Care Our Say (2006). The King"s Fund


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):